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ABSTRACT. The main protease of the SARS-CoV-2 virus, SARS-CoV-2 Mpro, can be discovered as a 
promising target to treat the COVID-19 pandemic. The peptide-based inhibitors may present better options 
than small molecules to inhibit SARS-CoV-2 Mpro. Ziziphus spina-christi species reported have a peptide-
based of alkaloids group, i.e., amphibine whose analogues can be identified the potential as an inhibitor of 
SARS-CoV-2 Mpro. The compound structure was drawn and optimized using semi-empirical AM-1 method 
using Quantum ESPRESSO v.6.6, while the biological activity using PASS. Prediction server and 
molecular docking simulation using MGLTools 1.5.6 with AutoDock 4.2 were performed. Afterward, the 
ADME profiles were predicted using the SWISS-ADME server. PASS server was predicting amphibine B-
F and H showed potency both as antiviral and as a protease inhibitor. The molecular docking simulation of 
amphibine analogues showed lower binding energy than the native ligand. The binding energy of the native 
ligand was −7.69 Kcal/mol compared to the lowest binding energy of amphibine analogues was −10.10 
Kcal/mol (amphibine-F). The ADME prediction showed that amphibine-F has the best bioavailability as an 
oral drug, amphibine-B, C, and D have good bioavailability, and amphibian-E and H have poor 
bioavailability. Concluded, amphibine B-F and H of amphibine analogues showed potency as COVID-19 
treatment targeting SARS-CoV-2 Mpro. 
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INTRODUCTION 
The Coronavirus disease 2019 has spread 
worldwide and still become a health problem 
that needs attention (Thompson, 2020; Zhu et 
al., 2020). Released on March 2021 in the 
present situational report from WHO, 3.8 
million COVID-19 new cases, and 64000 
recent deaths were reported globally. (WHO, 
2021). Clinically, COVID-19 can lead to severe 
respiratory complications and death with fever 
and respiratory symptoms (Calcagno et al., 
2020). 
SARS-CoV-2 main protease (Mpro), which 
can be crystallized along with its inhibitors, was 
one of the most promising targets for COVID-
19 drug discovery (Jin et al., 2020; Khaerunnisa 
et al., 2020; Mirza & Froeyen, 2020; Reiner et 
al., 2020), and become the key enzyme of viral 
polyprotein maturation, replication and 
transcription cycle (Dai et al., 2020; Fu et al., 
2020; Goyal & Goyal, 2020). SARS-CoV Mpro 
is resistant to peptide-like anti-HIV-1 drugs, 
hence SARS-CoV and SARS-CoV-2 SARS-
CoV-2 is closely related to, but distinct from the 
SARS-CoV branch on phylogenetic 
relationship (Choudhury & Mukherjee, 2020; 
Dong et al., 2020). Both virus rely on main 
protease associated with N3 inhibition (Griffin, 
2020). Small compounds may not be as 
effective as peptide-based inhibitors in the 
treatment of COVID-19 (Gentile et al., 2020; 
Han & Král, 2020; Maiti, 2020; Murdocca et 
al., 2021). 
The natural product compounds based on 
peptide-like from medicinal plants become our 
orientation research. Hence, they have not been 
explored intensively in drug discovery, 
especially those that can inhibit COVID-19 
(Dias et al., 2012; Harvey et al., 2015; Benarba 
& Pandiella, 2020; Lakshmi et al., 2020). Z. 
spina-christi as important medicinal plant (El 
Maaiden et al., 2019) is a deciduous tree that 
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generally comes from warm and subtropical 
climates, such as North Africa, South Europe, 
Mediterranean, tropical America, South and 
East of Asia, and others, including Indonesia 
(Kwape et al., 2013; Moossavi et al., 2017). 
There are many names for Z. spina-christi, 
known as Christ's thorn jujube, belongs to the 
Rhamnaceae family with large shade tree 
(Baghazadeh-Daryaii et al., 2017; Gorai et al., 
2019).  
The previous studies have reported that Z. 
spina-christi provided a variety of 
pharmacological activities, including 
antibacterial, antifungal, antioxidant, 
antihyperglycemic, and anti-diabetic (Kalayou 
et al., 2012; Ads et al., 2017; Al-Ghamdi et al., 
2017; Alotibi et al., 2020). According to our 
previous studies, the main phytochemicals were 
discovered in this plant include alkaloids, 
flavonoids, and saponins (Darusman & Fakih, 
2021). Tuenter et al. (2017) and Sakna et al. 
(2019) stated cyclopeptide alkaloids can be 
found in their stem-bark.  
To date, the need for a vaccine and antiviral 
development is increasing, especially those 
targeting SARS-CoV-2 Mpro. Computational 
approaches were demonstrated to predict the 
affinity and molecular behavior of amphibine 
analogues from the plant compound. We are 
interested in investigating the potency of the 
amphibine analogues (cyclopeptide alkaloids) 
from Z. spina-christi, as a promising future 
treatment for COVID-19 targeting SARS-CoV-
2 Mpro. 
 
MATERIALS AND METHODS 
Ligand preparation. The ligands chosen 
for this research were peptide alkaloids, 
amphibine analogues in Ziziphus spina-christi, 
i.e., amphibine A-H compounds. The 3D ligand 
structures were drawn and optimized based 
semi-empirical AM-1 method using Quantum 
ESPRESSO v.6.6 (Giannozzi et al., 2020). The 
research protocols were following our previous 
studies (Fakih et al., 2021). 
Receptor preparation. The 3D structure 
of SARS-CoV-2 Mpro was obtained from the 
Protein Data Bank (PDB) 
(http://www.rcsb.org/pdb/). The high 
resolution of the SARS-CoV-2 Mpro receptor 
(2.15 Å) with PDB ID: 6WTT was chosen (Ma 
et al., 2020). The receptor was complexed with 
boceprevir, an HCV protease inhibitor as a 
native ligand. Afterward, all the unique ligands 
and water molecules were removed from the 
receptor, and then the polar hydrogen and a 
charge (Kollman charge) were added to the 
protein structure. The protein preparation 
procedures were executed using MGLTools 
1.5.6 with AutoDock 4.2 (Tanbin et al., 2021). 
Biological activity prediction. The 
biological activity spectra of amphibine 
analogues were assessed using the PASS 
prediction web server 
(http://www.way2drug.com/PASSOnline/predi
ct.php) (Lagunin et al., 2000). The predicted 
spectrum was estimated as probable activity 
(Pa) and probable inactivity (Pi), based on 
structure-activity relationship analysis of the 
training set containing more than 205000 
compounds exhibiting more than 3750 kinds of 
biological activities. Pa and Pi values vary from 
0.000 to 1.000 since they are probabilities. The 
PASS prediction was interpreted and used 
flexibly, according to Anzali et al. (2001). 
Molecular docking simulation. The 
molecular docking simulation method was 
validated using RMSD calculation by re-
docked the crystallographic native ligand. The 
best conformation of docked native ligand was 
taken and superimposed with the native ligand 
before docked, and the Root-Mean-Square 
Deviation (RMSD) was calculated. The 
acceptable RMSD value must be less than 2.0 
Å (Bell & Zhang, 2019). Afterward, the 
amphibine analogues were docked into the 
binding pocket of the SARS-CoV-2 Mpro. The 
grid box was set with coordinates 5.499, 
27.197, and −11.76 (x, y, and z, respectively), 
and the dimensions of the grid box were 64, 60, 
and 60 (x, y, and z), and numbers of GA run 
was 100 (Atilgan & Hu, 2011). 
ADME prediction. We analyzed the 
adsorption, distribution, metabolism, and 
excretion (ADME) profile of the amphibine 
analogues, which could be used as a drug. We 
used the SWISS-ADME web server to predict 
the ADME profile 
(https://www.swissadme.ch), which allows the 
user to draw or input their molecules data and 
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provides the parameters such as lipophilicity, 
water-solubility, pharmacokinetics, drug-
likeness rules, and medicinal chemistry 
(Mahanthesh et al., 2020). 
 
RESULTS AND DISCUSSION 
Biological activity prediction. The PASS 
prediction web server's biological activity was 
carried out on amphibine analogues (A-H) 
compounds to see the level as a COVID-19 
main protease inhibitor (Table 1).  
The PASS web server predicts various 
biological activities of Amphibine analogues, 
but the focus of the research here is on the 
prediction of antiviral and protease inhibitor 
agents. All amphibine A-H were predicted to 
have an activity as antiviral agents. As protease 
enzyme inhibitors, amphibine B, C, D, E, F, and 
H showed activity, whereas amphibine A and G 
showed no activity. Amphibine-C showed the 
best-predicted activity spectrum of 0.298 for 
antiviral activity and 0.151 for protease 
inhibitor activity. Overall, in line with Abdelli 
et al. (2021) and Shah et al. (2021), amphibine 
B, C, D, E, F, and H compounds showed 
potency both as antiviral activity and protease 
inhibitors. 
Table 1. In silico prediction of activity spectra for 











































































Fig. 1. Chemical structure of amphibine A-H. 
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Molecular docking simulation. 
Molecular docking simulation study was 
performed on the crystal structure of SARS 
CoV-2 Mpro to assess the binding affinity 
potency of amphibine analogues (amphibine B, 
C, D, E, F, and H) that were previously 
predicted using the PASS website. The docking 
methods were validated to see the strength of 
binding mode prediction through re-docking 
the native ligand. The RMSD value of the 
native ligand obtained was 1.30 Å, which 
shows that the molecular docking method was 
valid. The amphibine analogues were then 
docked into the binding site of the crystal 
structure of SARS-CoV-2 Mpro. All of the 
docking results of amphibine A-H showed high 
binding energy and Ki compared to the native 
ligand (Table 2). The negative sign or the 
lowest binding energy is considered to be a 
stable binding affinity to the receptor. The 
binding energy of the native ligand was −7.69 
Kcal/mol. The amphibine analogues binding 
energy sort by lowest to highest were −10.10 
Kcal/mol (amphibine-F), −9.22 Kcal/mol 
(amphibine-E), −9.07 Kcal/mol (amphibine-B), 
−8.83 Kcal/mol (amphibine-H), −8.71 
Kcal/mol (amphibine-D), and −8.07 Kcal/mol 
(amphibine-C). 
 
Table 2. The binding energy and Ki of the amphibine of 





1 Native ligand − 7.69 2300 
2 Amphibine-B − 9.07 224.22 
3 Amphibine-C − 8.07 1220 
4 Amphibine-D − 8.71 411.85 
5 Amphibine-E − 9.22 173.95 
6 Amphibine-F − 10.10 39.51 
7 Amphibine-H − 8.83 335.11 
 
Molecular interactions. The ligand-
receptor interactions of the best binding mode 
of the Amphibine analogues were analyzed and 
compared to reference native ligand binding 
mode toward the SARS-CoV-2 Mpro. The 
tabulation data of the amino acid interactions 
were provided in Table 3, and the 2D 
interaction was provided in Fig. 2. Native 
ligand in its interactions, form hydrogen bonds 
with amino acids Glu166, His164, Phe140, 
Gln189, Cys145, and other types of interaction 
with residue Cys145 (unfavorable bump), 
His163 (unfavorable acceptor-acceptor), 
Pro168 (Pi-alkyl), Met165 (alkyl), His41 (alkyl 
& carbon-hydrogen bond), and His172 (carbon-
hydrogen bond). Amphibine-B showed 
hydrogen bond interaction with three amino 
acids, i.e., Glu166, Ser144, Asn142, and other 
types of interaction with amino acids Glu166 
(Pi-Anion), Pro168 (Pi-sigma), His41 (alkyl), 
Cys145 (Pi-alkyl), and His163 (unfavorable 
acceptor-acceptor). Amphibine-C showed 
hydrogen bond interaction with two amino 
acids, including Glu166 and Gln189. Other 
types of interaction with amino acids Gln189 
(carbon-hydrogen bond), Glu166 (carbon-
hydrogen bond), Pro168 (Pi-sigma), Met49 (Pi-
sulfur), His41 (Pi-alkyl & Pi-pi stacked), 
Leu167 (Pi-alkyl), Leu141 (alkyl). Amphibine-
D showed hydrogen bond interaction with one 
amino acid (Glu166) and other types of 
interaction with amino acids Met165 (alkyl & 
Pi-sulfur), His41 (carbon-hydrogen bond), 
Thr24 (carbon-hydrogen bond), Cys145 (Pi-
hydrogen bond). Amphibine-E showed 
hydrogen bond interaction with three amino 
acids, including Glu166, Gln192, and Gln189, 
and other types of interaction with amino acids 
Ala191 (Pi-alkyl), Pro168 (Pi-alkyl), His41 (Pi-
sigma). Amphibine-F showed hydrogen bond 
interaction with three amino acids, including 
His41, Glu166, and Gln189, and other types of 
interaction with amino acids His41 (Pi-sigma & 
unfavorable acceptor-Acceptor), Glu166 (Pi-
anion), Gln189 (carbon-hydrogen bond), 
Arg188 (carbon-hydrogen bond), Met165 
(alkyl). Amphibine-H showed hydrogen bond 
interaction with three amino acids, including 
Glu166, Gln192, and Thr190, and other types 
of interaction with amino acids Ala191 (Pi-
alkyl), Met165 (alkyl), Glu166 (carbon-






Vol 9(1), June 2021                                                                                                      Biogenesis: Jurnal Ilmiah Biologi 113 
 

























Table 3. Tabulation data of amino acid interactions of reference ligand (native ligand) compared to cyclopeptide alkaloids 
in SARS-CoV-2 Mpro. 
Ligands H-bond interactions Other type of interactions 
Reference native ligand 
(boceprevir) 
Glu166, His164, Phe140, Gln189, 
Cys145 
Cys145k, His163l, Pro168d, Met165c, 
His41c,f, His172f 
Amphibine-B Glu166, Ser144, Asn142 
Glu166a, Pro168b, His41c, Cys145d, 
His163e 
Amphibine-C Glu166, Gln189 
Gln189f, Glu166f, Pro168b, Met49g, 
His41d,h, Leu167d, Leu141c 
Amphibine-D Glu166 Met165c,g, His41f, Thr24f, Cys145i 
Amphibine-E Glu166, Gln192, Gln189 Ala191d, Pro168d, His41b 
Amphibine-F His41, Glu166, Gln 189 
His41b,e, Glu166j, Gln189f, Arg188f, 
Met165c 
Amphibine-H Glu166, Gln192, Thr190 Ala191d, Met165c, Glu166f, Phe140f 
Notes: a= Pi-anion; b= Pi-sigma; c= alkyl; d= Pi-alkyl; e= unfavorable acceptor-acceptor; f= carbon-hydrogen bond; g= Pi-sulphur; h= Pi-pi stacked; 
i= Pi-hydrogen bond; j= Pi-anion; k= unfavorable bump; l= unfavorable acceptor-acceptor. 
 
The hydrogen bond is an attractive 
interaction between a hydrogen atom from 
fragment X–H, and enhance receptor-ligand 
interactions (Arunan et al., 2011; Chen et al., 
2016). Native ligands binding mode still 
showed the highest intensity of hydrogen 
bonding (five hydrogen bonds), followed by 
amphibine-B, amphibine-E, amphibine-F, and 
amphibine-H with three numbers of the 
hydrogen bond, then amphibine-C (two 
hydrogen bond), and Amphibine-D (1 
hydrogen bond). The similarity of amino acid 
interaction types between the native ligand as a 
reference and amphibine analogues showed in 
the amphibine-B, amphibine-C, amphibine-D, 
and amphibine-H provided one type of 
hydrogen bond interaction similar (Glu166). 
The amphibine-E and amphibine-F compounds 
showed two similar hydrogen bond interactions 
to the reference ligand (Glu166 & Gln189). The 
other interactions, i.e., Pi-sigma, Pi-alkyl, and 
Pi-sulphur, mostly involve charge transfer 
assisting in intercalating the drug at the 
receptor-binding site. The highest number of 
amino acid interactions that form those other 
interactions were dominated by amphibine-C, 
amphibine-B, amphibine-F, amphibine-H, 






















Fig. 2. Molecular interaction of native ligand and amphibine B, C, D, E, F, and H 













ADME prediction. The amphibine 
analogues predicted before (B, C, D, E, F, and 
H) have been analyzed by ADME profile using 
SWISS-ADME (Fig. 3). The ADME profile 
was provided with radar that shown six 
predicted ADME parameters that are closely 
related to the oral bioavailability of a 
compound, including LIPO (lipophilicity), 
SIZE (size), POLAR (polarity), INSOLU 
(insolubility), INSATU (instauration), and 
FLEX (flexibility). The colored zone was a 
physical chemistry area that is suitable for oral 
bioavailability. Analysis of ADME profiles 
performed by radar showed Amphibine-B, 
Amphibine-C, Amphibine-D, and Amphibine-
F have suitable in polarity and insaturation 
following by oral drug bioavailability criteria, 
except for the lipophilicity, size, insolubility, 
and flexibility parameter. Amphibine-E 
compound radar is suitable for insaturation 
parameters. Amphibine-F compound radar 
shows a suitable in all parameters, i.e., 
lipophilicity, size, polarity, insolubility, 
insaturation, and flexibility. Amphibine-H 
compound radar shows a suitable in polarity, 





































Fig. 3. Administration, distribution, metabolism, and elimination (ADME) parameters for amphibine B, C, D, E, F, and 
H that were evaluated by SWISS-ADME. 
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Furthermore, lipinski analyses were 
performed to look for drug similarities or 
determine whether a chemical compound has 
specific pharmacological or biological activity 
has chemical and physical properties that make 
it pharmacokinetically effective in the human 
body, including ADME. In Lipinski drug-
likeness analysis, amphibine-B provided one 
violation (MW >500), amphibine-C provided 
one violation (MW >500), amphibine-D 
provided one violation (MW >500), amphibine-
E provided two violation (MW >500), and 
(NorO > 10), amphibine-F provided one 
violation (MW>500), Amphibine-H provided 
two violations (MW>500, NorO>10). The 
drug-likeness results showed amphibine-E and 
amphibine-H provided more than one violation, 
indicates poor bioavailability as oral drugs. 
Amphibine-B, C, D, and F showed one 
violation for drug-likeness criteria, indicates 
good bioavailability. In general, the amphibine-
F compounds showed the best bioavailability as 
an oral drug, amphibine-B, C, and D showed 
good bioavailability as an oral drug, and 
amphibine-E and H showed poor 
bioavailability as oral drugs. 
 
CONCLUSION 
The amphibine analogues from Ziziphus 
spina-christi species analyzed by biological 
activity, molecular docking, and ADME 
predictions were showed as potentially 
inhibitor candidates for the SARS-CoV-2 Mpro 
receptor. The biological activity prediction by 
PASS web server of amphibine analogues (A-
H) showed amphibine-B, C, D, E, F, and H have 
potential as antiviral and protease inhibitor 
agents. The molecular docking results of the 
amphibine-B, C, D, E, F, and H showed better 
binding affinity against SARS-CoV-2 Mpro 
compared to the native ligand as a reference 
inhibitor. These compounds also form 
interactions that are similar in some residues 
with the native ligand. The ADME prediction 
showed amphibine-F has the best 
bioavailability as an oral drug, amphibine-B, C, 
and D have good bioavailability as an oral drug 
from drug-likeness criteria, while amphibine-E 
and H show poor bioavailability as an oral drug. 
Concluded the Amphibine-B, C, D, E, F, and H 
have potential as a treatment of COVID-19 
through inhibits the protease enzyme of SARS-
CoV-2 Mpro, and some compounds can be 
formulated as oral administration (amphibine-
B, C, D, and F), and some in other 
administration (amphibine-E and H). 
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